Twist Bioscience Corp

NASDAQ:TWST   1:56:45 PM EDT
24.97
-1.36 (-5.16%)
Other Pre-Announcement

Twist Bioscience Reports Fiscal Q4 And Full Year Fiscal 2022 Financial Results

Published: 11/18/2022 12:57 GMT
Twist Bioscience Corp (TWST) - Twist Bioscience Reports Fiscal Fourth Quarter and Full Year Fiscal 2022 Financial Results.
Sees FY Revenue $261.0 Million to $269.0 Million.
Expect Revenue in Range of $261 Million to $269 Million for Full Year Fiscal 2023.
Expect Revenue of $350 Million for Full Year Fiscal 2024.
Total Revenues for Q4 of Fiscal 2022 Were $57.3 Million Compared to $38.0 Million for Same Period of Fiscal 2021.
Qtrly Loss per Share $0.91.
Q4 Earnings per Share View $-1.25, Revenue View $57.0 Million -- Refinitiv Ibes Data (analyst estimates).
Sees Q1 2023 Revenue to Be Approximately $54 Million.
FY2023 Revenue View $256.2 Million -- Refinitiv Ibes Data (analyst estimates).
Sees FY 2023 Net Loss to Be Approximately $260 Million.